Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Post by Sensanomeon Apr 30, 2020 10:37am
255 Views
Post# 30971061

From the article

From the article

Rep. Aderholt is a member of the powerful House Committee on Appropriations, which has jurisdiction over funding the operation of the federal government.

“I was proud to help this company, which has assets in Alabama and Tennessee, make connections within Alabama to ensure that the scientists at Webb had everything they needed to work on this antibody test,” Aderholt added. “I commend them for showing true American entrepreneurship in seeing a vital need and responding in record time.”

“Late last week, I was on a phone call with the FDA Commissioner Stephen Hahn and highlighted for him that the speed and accuracy of this test seem so promising,” Aderholt explained. “When I mentioned that the notification of the product would be submitted in the coming days, the commissioner agreed to be on the lookout for it.”

“It’s this type of testing that will allow us to reopen our economy in a safe manner and put an end to this pandemic,” Aderholt concluded.

The test will be manufactured in the United States.

Bullboard Posts